Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
REVIEW PAPER
Role of human microbiome and selected bacterial infections in the pathogenesis of rheumatoid arthritis
Submission date: 2017-09-27
Acceptance date: 2017-10-25
Online publication date: 2017-10-28
Publication date: 2017-12-31
Reumatologia 2017;55(5):242-250
KEYWORDS
TOPICS
ABSTRACT
Microorganisms inhabiting human body form a complex ecosystem. The mutual influence of the microbiome and the immune system of the host constitute the basis for numerous diseases, e.g. pseudomembranous colitis, inflammatory bowel disease, type 1 diabetes, atopic diseases, obesity, reactive arthritis. New molecular diagnostic methods and multi-center studies may help in understanding of the role of microbiota in health and disease. Rheumatoid arthritis has a multi-faceted etiology, and its causes are not entirely understood. There are indications for the influence of microbiomes of oral cavity, intestines, lungs and urinary tract on the development of rheumatoid arthritis. Interactions between microorganisms and human immune system play role in the pathogenesis of the disease.
REFERENCES (50)
1.
Kucharz EJ. Reumatoidalne zapalenie stawów. In: Wielka interna. Reumatologia. Puszczewicz M (ed.). Medical Tribune Polska, Warszawa 2010; 75-78.
2.
Tlaskalová-Hogenová H, Stepánková R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004; 93: 97-108.
3.
Vaahtovuo J, Munukka E, Korkeamäki M, et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008; 35: 1500-1505.
4.
Qin J, Li R, Raes J, et al. A human gut microbial gene catalog established by metagenomic sequencing. Nature 2010; 464: 59-65.
5.
Górecka D, Nowiński A, Augustynowicz-Kopeć E. [Microbiome of the lung.] Mikrobiom układu oddechowego. Pneumonol Alergol Pol 2014; 82: 481-485.
6.
Keeney KM, Yurist-Doutsch S, Arrieta MC, et al. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol 2014; 68: 217-2 35.
7.
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
8.
Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
9.
Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004; 4: 478-485.
10.
Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-118.
11.
Tukaj S, Lipińska B. Białka szoku termicznego w reumatoidalnym zapaleniu stawów: przyjaciel czy wróg? Postepy Hig Med Dosw (Online) 2011; 65: 427-436.
12.
Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-450.
13.
Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+) Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6: 234-242.
14.
Round JL, Lee SM, Li J, et al. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332: 974-977.
15.
Rogier R, Koenders MI, Abdollahi-Roodsaz S. Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res 2015; 2015: 527696.
16.
Ivanov II, Atarashi K, Manel N, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-498.
17.
Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-341.
18.
Breban MA, Moreau MC, Fournier C, et al. Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol 1993; 11: 61-64.
19.
Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014; 26: 10101-10107.
20.
Björk J, Kleinau S, Midtvedt T, et al. Role of the bowel flora for development of immunity to hsp 65 and arthritis in three experimental models. Scand J Immunol 1994; 40: 648-652.
21.
Liu X, Zou Q, Zeng B, et al. Analysis of fecal lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013; 67: 170-176.
22.
Zhang X, Zhang D, Jia H. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 2015; 2: 895-905.
23.
Scher JU, Sczesnak A, Longman RS, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202.
24.
Chen J, Wright K, Davis JM, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med 2016; 8: 43.
25.
De Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008; 35: 70-76.
26.
Chen HH, Huang N, Chen YM, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis 2013; 72: 1206-1211.
27.
Białowąs K, Swierkot J, Radwan-Oczko M. Rola Porphyromonas gingivalis w reumatoidalnym zapaleniu stawów i spondyloartropatiach zapalnych. Postepy Hig Med Dosw 2014; 68: 1171-1179.
28.
Erciyas K, Sezer U, Ustün K, et al. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Dis 2013; 19: 394-400.
29.
Białowąs K, Mendak-Ziółko M, Duś I, et al. Ocena częstości występowania zakażenia Porphyromonas gingivalis i wpływu leczenia periodontologicznego na aktywność choroby u pacjentów z reumatoidalnym zapaleniem stawów i spondyloartropatiami. Reumatologia 2016; 54 (Supl. 2): 57.
30.
Savioli C, Ribeiro AC, Fabri GM, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol 2012; 18: 180-184.
31.
Monsarrat P, Vergnes JN, Cantagrel A, et al. Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trial. Trials 2013; 14: 253.
32.
Kaur S, Bright R, Proudman SM, et al. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 113-122.
33.
Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol 2010; 37: 1801800-4.
34.
Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012; 64: 3083-3094.
35.
Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 2013; 65: 2545-2554.
36.
Scher JU, Joshua V, Artacho A, et al. The lung microbiota in early rheumatoid arthritis and autoimmunity. Microbiome 2016; 4: 60.
37.
Holecki M, Duława J, Hryniewicz W, et al. Rekomendacje diagnostyki, terapii i profilaktyki zakażeń układu moczowego u dorosłych. Narodowy Instytut Leków, Warszawa 2015; 7-18.
38.
Ebringer A, Ptaszynska T, Corbett M, et al. Antibodies to proteus in rheumatoid arthritis. Lancet 1985; 2: 305-307.
39.
Ebringer A, Khalafpour S, Wilson C. Rheumatoid arthritis and Proteus: a possible aetiological association. Rheumatol Int 1989; 9: 223-228.
40.
Wilson C, Thakore A, Isenberg D, et al. Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 1997; 16: 187-189.
41.
Senior BW, Anderson GA, Morley KD, et al. Evidence that patients with rheumatoid arthritis have asymptomatic ‘non-significant’ Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 1999; 38: 99-106.
42.
Arabski M, Fudala R, Koza A, et al. The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis. Clin Biochem 2012; 45: 1374-1382.
43.
Rashid T, Ebringer A. Rheumatoid arthritis is linked to Proteus – the evidence. Clin Rheumatol 2007; 26: 1036-1043.
44.
Ebringer A, Rashid T. Rheumatoid arthritis is caused by a Proteus urinary tract infection. APMIS 2014; 122: 363-368.
45.
Moreno J. Prevotella copri and the microbial pathogenesis of rheumatoid arthritis. Reumatol Clin 2015; 11: 61-63.
46.
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
47.
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227.
48.
McDonald D, Birmingham A, Knight R. Context and the human microbiome. Microbiome 2015; 3: 52.
49.
Forbes JD, Van Domselaar G, Bernstein CN. The Gut Microbiota in Immune-Mediated Inflammatory Diseases. Front Microbiol 2016; 7: 1081.
50.
Kumar PS, Griffen AL, Barton JA, et al. New bacterial species associated with chronic periodontitis. J Dent Res 2003; 82: 338-344.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
